Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Circulating tumour DNA reveals genetic traits of patients with intraductal carcinoma of the prostate
Jinge Zhao, Guangxi Sun, Sha Zhu, et al.
BJU International (2021) Vol. 129, Iss. 3, pp. 345-355
Closed Access | Times Cited: 25

Showing 25 citing articles:

Homologous recombination deficiency (HRD) score in aggressive prostatic adenocarcinoma with or without intraductal carcinoma of the prostate (IDC-P)
Sha Zhu, Jinge Zhao, Ling Nie, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 32
Clinical significance of stratifying prostate cancer patients through specific circulating genes
Seta Derderian, Edouard Jarry, Arynne Santos, et al.
Molecular Oncology (2025)
Open Access
Prospective observational study on the relationships between genetic alterations and survival in Japanese patients with metastatic castration-sensitive prostate cancer: the impact of IDC-P
Masashi Kato, Hiroyuki Sato, Yushi Naito, et al.
International Journal of Clinical Oncology (2025)
Open Access
Molecular complexity of intraductal carcinoma of the prostate
Sha Zhu, Nanwei Xu, Hao Zeng
Cancer Medicine (2024) Vol. 13, Iss. 2
Open Access | Times Cited: 4
Intraductal Carcinoma of the Prostate as a Cause of Prostate Cancer Metastasis: A Molecular Portrait
Helen Pantazopoulos, Mame-Kany Diop, Andrée‐Anne Grosset, et al.
Cancers (2022) Vol. 14, Iss. 3, pp. 820-820
Open Access | Times Cited: 16
Ductal, intraductal, and cribriform carcinoma of the prostate: Molecular characteristics and clinical management
Yibo Shi, Hanzhang Wang, Borivoj Golijanin, et al.
Urologic Oncology Seminars and Original Investigations (2024) Vol. 42, Iss. 5, pp. 144-154
Closed Access | Times Cited: 3
Unveiling the latest insights into Androgen Receptors in Prostate Cancer
Suleiman Zakari
International journal of medical biochemistry/International journal of medical biochemistry : (2024), pp. 101-113
Open Access | Times Cited: 3
Current progress and novel strategies that target CDK12 for drug discovery
Peng Lei, Jifa Zhang, Pei‐Yu Liao, et al.
European Journal of Medicinal Chemistry (2022) Vol. 240, pp. 114603-114603
Closed Access | Times Cited: 15
Genomic and Evolutionary Characterization of Concurrent Intraductal Carcinoma and Adenocarcinoma of the Prostate
Jinge Zhao, Nanwei Xu, Sha Zhu, et al.
Cancer Research (2023) Vol. 84, Iss. 1, pp. 154-167
Closed Access | Times Cited: 8
Our Current Understanding of the Heterogeneity in Prostate Cancer and Renal Cell Carcinoma
Sha Zhu, Junru Chen, Hao Zeng
Journal of Clinical Medicine (2023) Vol. 12, Iss. 4, pp. 1526-1526
Open Access | Times Cited: 6
Therapeutic sensitivity to standard treatments in BRCA positive metastatic castration-resistant prostate cancer patients—a systematic review and meta-analysis
Tamás Fazekas, Ádám Széles, Brigitta Teutsch, et al.
Prostate Cancer and Prostatic Diseases (2022) Vol. 26, Iss. 4, pp. 665-672
Open Access | Times Cited: 8
Recent insights on the clinical, pathological, and molecular features of intraductal carcinoma of the prostate
Yushi Naito, Masashi Kato, Jun Nagayama, et al.
International Journal of Urology (2023) Vol. 31, Iss. 1, pp. 7-16
Open Access | Times Cited: 4
The presence of intraductal carcinoma of prostate is a risk factor for poor pathologic response in men with high-risk prostate cancer receiving neoadjuvant therapy
Binyu Wang, Yao Fu, Mengxia Chen, et al.
Urologic Oncology Seminars and Original Investigations (2024) Vol. 42, Iss. 3, pp. 67.e9-67.e15
Closed Access | Times Cited: 1
Genomic Features and Clinical Implications of Intraductal Carcinoma of the Prostate
Minyong Kang, Hyunwoo Lee, Sun‐ju Byeon, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 13125-13125
Open Access | Times Cited: 9
Clinical utility of intraductal carcinoma of the prostate in treatment selection for metastatic hormone‐sensitive prostate cancer
Yushi Naito, Masashi Kato, Hideji Kawanishi, et al.
The Prostate (2022) Vol. 83, Iss. 4, pp. 307-315
Closed Access | Times Cited: 6
Detection of intraductal carcinoma in prostate cancer patients with small tumor volume
Nobushige Takeshita, Shinichi Sakamoto, Yasutaka Yamada, et al.
The Prostate (2023) Vol. 83, Iss. 6, pp. 580-589
Closed Access | Times Cited: 2
Associations Between Intraductal Prostate Cancer and Metastases Following Radical Prostatectomy in Men With Prostate Cancer in the Veterans Affairs Database
Tyler J. Nelson, Abhishek Kumar, Vinit Nalawade, et al.
Clinical Genitourinary Cancer (2023) Vol. 21, Iss. 4, pp. 452-458
Closed Access | Times Cited: 2
Unlocking the Secrets of Androgen Receptors in the Susceptibility, Progression, and Treatment of Prostate Cancer
Suleiman Zakari, Christogonus C. Ekenwaneze, Emmanuel Amadi, et al.
(2023)
Open Access | Times Cited: 2
Unlocking the Secrets of Androgen Receptors in the Susceptibility, Progression, and Treatment of Prostate Cancer
Suleiman Zakari, Christogonus C. Ekenwaneze, Emmanuel Amadi, et al.
(2023)
Open Access | Times Cited: 2
SPOP Gene Mutations in Prostate Cancer: Deciphering Their Role in Disease Characterization and Targeted Interventions on AR Signaling
Suleiman Zakari
(2023)
Open Access | Times Cited: 2
Chronological Liquid Biopsy Reveals the Impact of Platinum-Based Chemotherapy on a Prostate Cancer Patient’s CDK12 Mutation: A Case Report
Sha Zhu, Yige Bao, Linmao Zheng, et al.
OncoTargets and Therapy (2022) Vol. Volume 15, pp. 947-952
Open Access | Times Cited: 3
GRIN3A: A biomarker associated with a cribriform pattern and poor prognosis in prostate cancer
Mari Bogaard, Jonas M. Strømme, Susanne G. Kidd, et al.
Neoplasia (2024) Vol. 55, pp. 101023-101023
Open Access
The therapeutic efficacy of radical prostatectomy and external beam radiation therapy in patients with different pathological patterns of prostate cancer
Jinge Zhao, Guangxi Sun, Fengnian Zhao, et al.
Asian Journal of Surgery (2022) Vol. 46, Iss. 10, pp. 4178-4185
Open Access | Times Cited: 1
Cell-free DNA in the management of prostate cancer: Current status and future prospective
Wei He, Yu‐Tian Xiao, Yan Shi, et al.
Asian journal of urology (2022) Vol. 10, Iss. 3, pp. 298-316
Open Access | Times Cited: 1
Clinical transformation and basic research progress of intraductal carcinoma of the prostate
Jingge Zhao, Guangxi Sun, Sha Zhu, et al.
Scientia Sinica Vitae (2022) Vol. 52, Iss. 11, pp. 1626-1635
Closed Access
Page 1

Scroll to top